← Back to directory

Massimo Breccia

Researcher Next ID · RN-034955

Researcher · Medicine

Policlinico Umberto I

Rome, Italy

Accepting doctoral researchersFunding unknown
Works count
1,059
Citation count
18,015
H-index
60
i10-index
387

Research interests

Medicine
Chronic Myeloid Leukemia Treatments
Chronic Lymphocytic Leukemia Research
Acute Myeloid Leukemia Research
Myeloproliferative Neoplasms: Diagnosis and Treatment
Eosinophilic Disorders and Syndromes

Publications

  • Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure

    New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1902328

  • Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non–High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial

    Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2016.67.1982

  • European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia

    Leukemia · 2016 · https://doi.org/10.1038/leu.2016.104

  • Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia

    New England Journal of Medicine · 2013 · https://doi.org/10.1056/nejmoa1300874

  • Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population

    Blood · 2011 · https://doi.org/10.1182/blood-2011-04-347575

  • Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group

    Blood · 2010 · https://doi.org/10.1182/blood-2010-03-276196

Current projects

    No projects listed.